Drug intelligence / Profile preview

canine distemper vaccine + canine adenovirus vaccine + canine parainfluenza vaccine + canine parvovirus vaccine

Development stage
Unknown
Lead developer
Merck Animal Health
Modality
Vaccines & Immunotherapeutics
Administration
Subcutaneous, Intramuscular
01

Overview

The **canine distemper vaccine + canine adenovirus vaccine + canine parainfluenza vaccine + canine parvovirus vaccine** is a multivalent combination vaccine, commonly known as DA2PP or equivalent (e.g., DAPP, DHPP), designed for dogs to prevent four core viral diseases: canine distemper (a fatal paramyxovirus affecting respiratory, gastrointestinal, and nervous systems), canine adenovirus types 1 and 2 (causing hepatitis and respiratory disease like kennel cough), canine parainfluenza (a contributor to kennel cough with respiratory symptoms), and canine parvovirus (a highly contagious enteritis leading to severe dehydration and death, especially in puppies).[1][2][3][4][5] It typically uses modified live viruses, including high-titer CPV-2b for parvovirus and CAV-2 for cross-protection against CAV-1, administered as a series starting at 6-8 weeks of age with boosters at 12-16 weeks, annually at 1 year, and then every 1-3 years. This core vaccine is recommended by veterinarians for all dogs due to the lethality of these viruses, which have no effective antiviral cures, and offers broad protection against highly contagious pathogens spread via direct contact or aerosols.[1][3][4][7]

Brand names
DA2PPDA-2PPDA 2PPDA2PPCDA-2PPCDA 2PPCDAPPDHPPNOBIVAC Canine 1-DAPPvSpectra 5Spectra5Spectra-5DAPPvDA2PPVDA-2PPVDA 2PPV
Other names
5-way vaccinedistemper-adenovirus-parainfluenza-parvovirus vaccine
02

Targets

Canine parainfluenza virus surface glycoproteinsCDV (Canine distemper virus)CAdV-2 (Canine adenovirus type 2)Canine adenovirus type 1 antigens

Beyond the preview

Go deeper on canine distemper vaccine + canine adenovirus vaccine + canine parainfluenza vaccine + canine parvovirus vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on canine distemper vaccine + canine adenovirus vaccine + canine parainfluenza vaccine + canine parvovirus vaccine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call